Improving Heart Failure Care in Minority Communities
Study Details
Study Description
Brief Summary
For congestive heart failure (CHF) patients with systolic dysfunction, a randomized controlled trial compared nurse-based disease management to address problems in patient and clinician management with usual care for effects on hospitalization and functioning among ethnically-diverse patients in ambulatory practices.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Congestive heart failure (CHF) disproportionately afflicts Black and elderly people, and is a leading cause of hospitalization > 65 years. Although effective therapies can improve functioning and survival in patients with systolic dysfunction, many may not be receiving the full benefit of existing knowledge, including counseling on self-management and appropriate doses of medications. Patients play a critical role in managing a chronic condition such as CHF, but may not have the skills to do so. Clinicians may not provide counseling or medications consistent with evidence-based guidelines.
Systematic reviews of clinical-behavior change have suggested that interventions targeted to specific problems are more likely to be successful. Based on shortfalls identified in patient self-management and clinical care in Harlem, a predominately non-white area in northern Manhattan, we tailored a nurse-management intervention to address the problems documented, and evaluated its effectiveness in a randomized controlled trial. This trial among primarily-minority patients addresses important gaps in this literature: the study targeted problems documented among CHF patients in Harlem, enrolled patients from ambulatory practices, randomly assigned patients between nurse-management and usual care, and evaluated their subsequent health-related outcomes. Hypothesis: the nurse-management program would result in nurse patients' having fewer hospitalizations and reporting better functioning.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Nurse-management nurse-led intervention focused on specific management problems |
Behavioral: Nurse-management
bilingual nurses counseled patients on diet, medication adherence, and self-management of symptoms through an initial visit and regularly scheduled follow-up telephone calls and facilitated evidence-based changes to medications in discussions with patients' clinicians.
Other Names:
|
No Intervention: Usual Care Usual care as control group |
Outcome Measures
Primary Outcome Measures
- Short Form 12 questionnaire [12 months]
self-reported physical functioning as measured by the physical component score on the Short Form 12 questionnaire
Secondary Outcome Measures
- Number of hospitalizations [12 months]
number of hospitalizations in 12 month period
- Minnesota Living with Heart Failure Questionnaire [12 months]
self-reported physical functioning as measured by the physical component score on the Minnesota Living with Heart Failure Questionnaire
- Number of deaths [12 months]
deaths measured by the reporting of death by patient family or recording in the National Death Index
Eligibility Criteria
Criteria
Inclusion Criteria:
-
• adults >18 years,
-
systolic dysfunction documented on a cardiac test (echocardiography, radionuclide ventriculography, myocardial stress sestamibi/thallium testing, or left-heart catheterization),
-
English- or Spanish-speaking,
-
community-dwelling at enrollment, and
-
current patient in a general medicine, geriatrics, or cardiology clinic or office at a participating site.
Exclusion Criteria:
-
• medical conditions that prevented a patient's interacting with the nurse, including blindness, deafness, and cognitive impairment;
-
medical conditions that required individualized management that might differ from standard protocol, namely pregnancy, renal dialysis, and terminal illness; and
-
procedures that corrected systolic dysfunction, such as heart transplantation.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Mount Sinai School of Medicine | New York | New York | United States | 10029-6574 |
2 | Metropolitan Hospital | New York | New York | United States | 10029 |
3 | North General Hospital | New York | New York | United States | 10035 |
4 | Harlem Hospital | New York | New York | United States | 10037 |
Sponsors and Collaborators
- Icahn School of Medicine at Mount Sinai
- Agency for Healthcare Research and Quality (AHRQ)
Investigators
- Principal Investigator: Jane Sisk, Ph.D., Icahn School of Medicine at Mount Sinai
- Principal Investigator: Paul Hebert, MD, Icahn School of Medicine at Mount Sinai
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- GCO 99-0347
- AHRQ R01 HS10402-01